Category: Osteopathy

BioDlink, a leading global CDMO, extends its congratulations to Junshi Biosciences, on receiving Investigational New Drug (IND) approval

Osteopathy training explained Written by London School of Osteopathy September 10, 2025 Osteopathy training explained: What it looks like and what to expect If you’re considering a career in osteopathy, it’s essential to understand what the journey to becoming a qualified osteopath actually looks like. Osteopathy combines science with hands-on practice, allowing you to make […]

In a three-year study involving more than 5,000 residents of Israel before and after the mass traumatic events of October 7, 2023, those who watched extensive media coverage of the attacks were found to be more likely to develop post-traumatic stress disorder (PTSD).

A new University of South Florida study published in Menopause highlights a largely overlooked health issue: voice changes that many women experience during menopause, often triggered by falling levels of estrogen and progesterone.

Today, Breakthrough Discoveries for thriving with Bipolar Disorder (BD²) announced the opening of a fourth round of funding opportunities for the Discovery Research program. BD² invites scientists across all disciplines to apply for up to $4.5 million per grant.

The university stage, particularly its beginning, is a time of tension and emotional stress for young students-many of whom are under the age of 20.

The human papillomavirus (HPV) vaccine is one of the few vaccines proven to prevent cancer-so why have only 61% of teens 13-17 and far lower percentages of younger children received the potentially life-saving shots?

Increased risk for anxiety may begin before birth, shaped by infection or stressful events during pregnancy, according to a new preclinical study from researchers at Weill Cornell Medicine.

​Neurocognitive impairments are classified by pathological changes with potential for destruction of neural tissue. One change known to occur in neurodegenerative disorders is an accumulation of proteins causing pathological damage.

An unusual therapy developed at The Jackson Laboratory (JAX) could change the way the world fights influenza, one of the deadliest infectious diseases.